Image via Financial Post
Last updated
Altus Group: Restructuring
Completed substantial issuer bid, buying back 3.8M shares at C$52 per share, indicating capital optimization strategy
Source: Financial Post
The leadership read
Restructuring typically reshapes sales leadership bench strength toward transformation and turnaround capability.
Market context: The wider read — a Talent Market Index of 108 (Hot), up 2.4 month-on-month — shows EMEA signal flow easing (-8.7pts).
Altus Group: 1 signal in the last 90 days — in line with the Sales median of 1 across 25 tracked companies; 0.1% of MitchelLake's EMEA signal flow.
MitchelLake in this thematic
From the MitchelLake archive
More signals across Sales
Ma Activity · EMEA
Datadog →Datadog acquired Adaptive ML to accelerate AI R&D capabilities. The acquisition will integrate Adaptive ML into Datadog's AI lab to build frontier AI infrastructure for observability and security research.
Partnership · EMEA
Trustpilot →Trustpilot integrated customer review functionality into Shopify stores, expanding distribution and embedded review capabilities.
Partnership · EMEA
NICE Actimize →NICE Actimize won a major mandate with DNB Bank ASA (Norway's largest financial services group) to deploy X-Sight Enterprise platform for fraud and financial crime detection. Infosys selected as systems integration partner for end-to-end modernization.
Partnership · EMEA
Napier AI →Napier AI partnered with Concentrix to expand its Continuum compliance platform into ANZ markets, leveraging Concentrix's scale and transformation expertise to serve financial services organizations.
Capital Raising · EMEA
Liftoff Mobile →Liftoff Mobile completed IPO on Nasdaq, raising $437 million. CEO Jeremy Bondy led the company public after market stabilization, achieving tenth consecutive quarter of growth. Backed by Blackstone private equity.
Product Launch · EMEA
Novo Nordisk →Novo Nordisk's investigational zenagamtide (once-weekly GLP-1 receptor agonist) demonstrated significant A1C reductions and up to 14.6% weight loss in Phase 2 study of adults with type 2 diabetes, presented at ADA 2026
Intelligence powered by Autonodal ↗